NCT04228822

Brief Summary

Good glycemic control in individuals with Type 1 diabetes (T1D), has been proven to reduce the risk of diabetes-related complications. Despite technological advances such as the use of insulin delivery devices and continuous glucose monitoring, the average glycemic control in T1D is poor. Though dietary management plays a major role in the overall management of T1D, and it is often classified as the most challenging aspect of treatment, the 2019 Standards of Medical Care in Diabetes for children and adolescents do not clearly address dietary management. As carbohydrate is the macronutrient with the greatest impact on blood glucose, it is reasonable to suggest that carbohydrate reduction will minimize postprandial glucose excursions and improve diabetes control. For this reason, low carbohydrate diets (LCD) have gained popularity, and observational studies report positive glycemic outcomes. However, to date, scientific evidence from randomized trials on the impact of LCD in children with T1D is lacking. Thus, the over-arching goal of this pilot study is to evaluate the feasibility and safety of a low carbohydrate diet in children with T1D, and as an exploratory aim, we will evaluate the efficacy of LCD on glycemic control.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 11, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 14, 2020

Completed
10 months until next milestone

Study Start

First participant enrolled

November 10, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2022

Completed
Last Updated

March 9, 2022

Status Verified

March 1, 2022

Enrollment Period

1.3 years

First QC Date

December 11, 2019

Last Update Submit

March 7, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Number of hypoglycemic events

    Using a continuous glucose monitor (CGM) and home glucose meter, investigators will calculate the number of hypoglycemic events (glucose values \<70 mg/dL but ≥ 54 mg/dL and those \<54 mg/dL), number of severe hypoglycemia and time spent in hypoglycemia (values \<70 mg/dL but ≥ 54 mg/dL and \<54 mg/dL).

    6 month study period

  • Episodes of diabetes related visits to the hospital, DKA

    Investigators will obtain data prospectively from medical records and will estimate the frequency of DKA, diabetes related hospitalizations / emergency department visits.

    6 month study period

  • Dyslipidemia

    Investigators will evaluate the changes in LDL levels among the study groups.

    6 month study period

Secondary Outcomes (2)

  • Glycemic control

    6 month duration of the study

  • Glucose variability

    6 month study period

Study Arms (2)

Low carb diet intervention group

EXPERIMENTAL

Low carbohydrate diet defined as 25-35% of total energy intake

Other: Low carbohydrate diet

Control

NO INTERVENTION

Standard diet defined as 45-65% total energy intake

Interventions

25-35% of carbohydrates from total energy intake

Low carb diet intervention group

Eligibility Criteria

Age5 Years - 11 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patients 5-11 years of age, with history of Type 1 diabetes for longer than 2 years,
  • No carbohydrate restrictions at the time of recruitment.
  • No medications that could affect appetite
  • Regular attendance at the clinic (3-4 times per year),
  • Glycated hemoglobin (HbA1c) \<10%.

You may not qualify if:

  • Impaired renal or liver function,
  • Chronic seizures or global developmental delay,
  • Diagnosed with ADHD and/or on ADHD medications
  • Use of drugs other than insulin affecting glucose metabolism
  • Severe eczema
  • Celiac disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St Louis Children's Hospital

St Louis, Missouri, 63110, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Interventions

Diet, Carbohydrate-Restricted

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: 20 participants will be randomized to the intervention group (low carbohydrate diet) and 20 participants will be randomized to the control group
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 11, 2019

First Posted

January 14, 2020

Study Start

November 10, 2020

Primary Completion

February 28, 2022

Study Completion

February 28, 2022

Last Updated

March 9, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations